BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25239720)

  • 1. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection.
    Chung P; Currie B; Guo Y; Talansky M; Brown S; Ostrowsky B
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S264-8. PubMed ID: 25239720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons learned from implementing Clostridium difficile-focused antibiotic stewardship interventions.
    Ostrowsky B; Ruiz R; Brown S; Chung P; Koppelman E; van Deusen Lukas C; Guo Y; Jalon H; Sumer Z; Araujo C; Sirtalan I; Brown C; Riska P; Currie B
    Infect Control Hosp Epidemiol; 2014 Oct; 35 Suppl 3():S86-95. PubMed ID: 25222903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.
    Baxter R; Ray GT; Fireman BH
    Infect Control Hosp Epidemiol; 2008 Jan; 29(1):44-50. PubMed ID: 18171186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection.
    Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR
    Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors.
    Debast SB; Vaessen N; Choudry A; Wiegers-Ligtvoet EA; van den Berg RJ; Kuijper EJ
    Clin Microbiol Infect; 2009 May; 15(5):427-34. PubMed ID: 19416295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.
    Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL
    World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
    Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
    Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
    Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridium difficile infection after cardiac surgery: prevalence, morbidity, mortality, and resource utilization.
    Keshavamurthy S; Koch CG; Fraser TG; Gordon SM; Houghtaling PL; Soltesz EG; Blackstone EH; Pettersson GB
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):3157-65.e1-5. PubMed ID: 25242055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
    Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
    JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of Clostridium difficile is similar worldwide over two decades despite widespread use of broad-spectrum antibiotics: an analysis done at the University Hospital of Zurich.
    Büchler AC; Rampini SK; Stelling S; Ledergerber B; Peter S; Schweiger A; Ruef C; Zbinden R; Speck RF
    BMC Infect Dis; 2014 Nov; 14():607. PubMed ID: 25425433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Assessment Across the Healthcare Continuum: Risk of Hospital-Associated Clostridium difficile Infection Due to Outpatient and Inpatient Antibiotic Exposure.
    Tartof SY; Rieg GK; Wei R; Tseng HF; Jacobsen SJ; Yu KC
    Infect Control Hosp Epidemiol; 2015 Dec; 36(12):1409-16. PubMed ID: 26387888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication risk factors associated with healthcare-associated Clostridium difficile infection: a multilevel model case-control study among 64 US academic medical centres.
    Pakyz AL; Jawahar R; Wang Q; Harpe SE
    J Antimicrob Chemother; 2014 Apr; 69(4):1127-31. PubMed ID: 24327619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008.
    Feuerstadt P; Das R; Brandt LJ
    Am J Gastroenterol; 2014 Aug; 109(8):1265-76. PubMed ID: 25001255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.